Avidity Partners Management L.P. 13F annual report

Avidity Partners Management L.P. is an investment fund managing more than $2.35 trillion ran by Delmer Iii. There are currently 84 companies in Mr. Iii’s portfolio. The largest investments include Intuitive Surgical Inc and Boston Scientific, together worth $199 billion.

Limited to 30 biggest holdings

$2.35 trillion Assets Under Management (AUM)

As of 7th August 2024, Avidity Partners Management L.P.’s top holding is 245,000 shares of Intuitive Surgical Inc currently worth over $109 billion and making up 4.6% of the portfolio value. Relative to the number of outstanding shares of Intuitive Surgical Inc, Avidity Partners Management L.P. owns more than approximately 0.1% of the company. In addition, the fund holds 1,170,100 shares of Boston Scientific worth $90.1 billion, whose value grew 15.1% in the past six months. The third-largest holding is Natera Inc worth $83 billion and the next is Arvinas Inc worth $79.5 billion, with 2,987,845 shares owned.

Currently, Avidity Partners Management L.P.'s portfolio is worth at least $2.35 trillion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Avidity Partners Management L.P.

The Avidity Partners Management L.P. office and employees reside in Dallas, Texas. According to the last 13-F report filed with the SEC, Delmer Iii serves as the Chief Compliance Officer at Avidity Partners Management L.P..

Recent trades

In the most recent 13F filing, Avidity Partners Management L.P. revealed that it had opened a new position in Incyte and bought 529,000 shares worth $32.1 billion. This means they effectively own approximately 0.1% of the company. Incyte makes up 1.9% of the fund's Health Care sector allocation and has decreased its share price by 4.9% in the past year.

The investment fund also strengthened its position in Intuitive Surgical Inc by buying 19,000 additional shares. This makes their stake in Intuitive Surgical Inc total 245,000 shares worth $109 billion. Intuitive Surgical Inc soared 53.8% in the past year.

On the other hand, there are companies that Avidity Partners Management L.P. is getting rid of from its portfolio. Avidity Partners Management L.P. closed its position in Fusion Pharmaceuticals on 14th August 2024. It sold the previously owned 6,500,328 shares for $139 billion. Delmer Iii also disclosed a decreased stake in Boston Scientific by 0.4%. This leaves the value of the investment at $90.1 billion and 1,170,100 shares.

One of the largest hedge funds

The two most similar investment funds to Avidity Partners Management L.P. are Journey Strategic Wealth and Tiedemann Advisors. They manage $2.35 trillion and $2.35 trillion respectively.


Delmer Iii investment strategy

Avidity Partners Management L.P.’s portfolio is diversified across 5 sectors. Currently, their heaviest sector is Health Care — making up 72.9% of the total portfolio value. The fund focuses on investments in the United States as 63.1% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up 20% of the total holdings value. On the other hand, small-cap stocks make up only 8.3% of the portfolio. The average market cap of the portfolio companies is close to $28.7 billion.

The complete list of Avidity Partners Management L.P. trades based on 13F SEC filings

These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security Shares Owned Value Allocation
Fusion Pharmaceuticals Inc.
Closed
6,500,328
$138,586,993,000
Intuitive Surgical Inc
8.41%
245,000
$108,988,250,000 4.63%
Boston Scientific Corp.
40.18%
1,170,100
$90,109,401,000 3.83%
Natera Inc
4.58%
766,500
$83,004,285,000 3.53%
Arvinas Inc
0.09%
2,987,845
$79,536,434,000 3.38%
Acadia Healthcare Company In
11.44%
1,120,000
$75,644,800,000 3.21%
Dianthus Therapeutics Inc
7.35%
2,917,231
$75,497,938,000 3.21%
Syndax Pharmaceuticals Inc
38.24%
3,335,000
$68,467,550,000 2.91%
Neurocrine Biosciences, Inc.
8.48%
491,000
$67,595,970,000 2.87%
Avantor, Inc.
14.51%
3,086,000
$65,423,200,000 2.78%
Align Technology, Inc.
Closed
189,000
$61,976,880,000
Cigna Group (The)
No change
184,500
$60,990,165,000 2.59%
Jazz Pharmaceuticals plc
6.76%
544,500
$58,114,485,000 2.47%
Eli Lilly Co
Closed
70,000
$54,457,200,000
Alnylam Pharmaceuticals Inc
8.64%
222,000
$53,946,000,000 2.29%
Regeneron Pharmaceuticals, Inc.
29.41%
48,000
$50,449,440,000 2.14%
Illumina Inc
3.00%
478,000
$49,893,640,000 2.12%
Tenet Healthcare Corp.
38.10%
372,000
$49,487,160,000 2.10%
Abbvie Inc
22.38%
277,800
$47,648,256,000 2.02%
Alpine Immune Sciences Inc
Closed
1,174,700
$46,565,108,000
Thermo Fisher Scientific Inc.
118.58%
80,000
$44,240,000,000 1.88%
CVS Health Corp
Closed
545,000
$43,469,200,000
Structure Therapeutics Inc
24.42%
1,075,000
$42,215,250,000 1.79%
Blueprint Medicines Corp
10.09%
383,000
$41,279,740,000 1.75%
Cg Oncology Inc
10.90%
1,296,225
$40,921,823,000 1.74%
Merck Co Inc
35.26%
325,000
$40,235,000,000 1.71%
Ultragenyx Pharmaceutical In
2.84%
960,000
$39,456,000,000 1.68%
IDEAYA Biosciences, Inc.
39.68%
1,117,000
$39,217,870,000 1.67%
Danaher Corp.
4.31%
150,000
$37,477,500,000 1.59%
Janux Therapeutics Inc
118.67%
840,219
$35,196,774,000 1.50%
United Therapeutics Corp
49.31%
110,000
$35,040,500,000 1.49%
Incyte Corp.
Opened
529,000
$32,067,980,000 1.36%
Surgery Partners Inc
9.59%
1,306,477
$31,081,088,000 1.32%
Perspective Therapeutics Inc
Opened
3,037,668
$30,285,550,000 1.29%
Axsome Therapeutics Inc
12.76%
376,000
$30,268,000,000 1.29%
Caribou Biosciences Inc
Closed
5,785,352
$29,736,709,000
Xenon Pharmaceuticals Inc
6.20%
754,000
$29,398,460,000 1.25%
Dexcom Inc
46.41%
259,000
$29,365,420,000 1.25%
Revolution Medicines Inc
18.90%
755,000
$29,301,550,000 1.25%
Insmed Inc
Opened
430,000
$28,810,000,000 1.22%
Intra-Cellular Therapies Inc
33.33%
400,000
$27,396,000,000 1.16%
Cullinan Therapeutics Inc
Opened
1,559,826
$27,203,365,000 1.16%
Glaukos Corporation
No change
224,000
$26,510,400,000 1.13%
Neurogene Inc
56.38%
727,537
$26,475,071,000 1.12%
Argenx Se
Opened
60,500
$26,017,420,000 1.11%
Mirum Pharmaceuticals Inc
36.03%
731,104
$24,996,446,000 1.06%
Establishment Labs Holdings Inc
136.00%
531,000
$24,128,640,000 1.03%
Immunovant Inc
79.80%
908,000
$23,971,200,000 1.02%
Rocket Pharmaceuticals Inc
7.32%
1,100,000
$23,683,000,000 1.01%
Lantheus Holdings Inc
39.58%
290,000
$23,284,100,000 0.99%
Vaxcyte, Inc.
No change
284,000
$21,444,840,000 0.91%
Apogee Therapeutics Inc
26.53%
487,000
$19,163,450,000 0.81%
Mckesson Corporation
Closed
33,300
$17,877,105,000
Jasper Therapeutics Inc
2.89%
782,000
$17,751,400,000 0.75%
Neumora Therapeutics Inc.
No change
1,800,000
$17,694,000,000 0.75%
Legend Biotech Corp
40.45%
398,000
$17,627,420,000 0.75%
Gilead Sciences, Inc.
Opened
255,000
$17,495,550,000 0.74%
Phathom Pharmaceuticals Inc
6.63%
1,620,000
$16,686,000,000 0.71%
Vera Therapeutics Inc
Closed
383,500
$16,536,520,000
Astrazeneca plc
28.13%
205,000
$15,987,950,000 0.68%
Keros Therapeutics, Inc.
63.66%
343,200
$15,684,240,000 0.67%
Biohaven Ltd
500.00%
450,000
$15,619,500,000 0.66%
Sanofi
Opened
315,000
$15,283,800,000 0.65%
Regenxbio Inc
No change
1,300,064
$15,210,749,000 0.65%
Context Therapeutics Inc
Opened
7,419,355
$14,875,807,000 0.63%
Exact Sciences Corp.
Opened
338,500
$14,301,625,000 0.61%
Astria Therapeutics Inc
Closed
982,000
$13,821,650,000
Privia Health Group Inc
No change
764,200
$13,281,796,000 0.56%
Cytokinetics Inc
Closed
166,000
$11,638,260,000
Radnet Inc
Closed
238,000
$11,581,080,000
Acadia Pharmaceuticals Inc
Closed
588,500
$10,881,365,000
Newamsterdam Pharma Company
17.75%
559,300
$10,744,153,000 0.46%
Immunome, Inc.
No change
873,891
$10,574,081,000 0.45%
Immunic, Inc.
No change
8,902,972
$9,882,299,000 0.42%
Corbus Pharmaceuticals Hldgs
Opened
215,600
$9,755,900,000 0.41%
Cybin Inc
No change
34,884,000
$9,453,564,000 0.40%
Syros Pharmaceuticals Inc.
No change
1,673,538
$8,635,456,000 0.37%
Cogent Biosciences, Inc.
124.52%
1,000,706
$8,435,952,000 0.36%
Immunocore Hldgs Plc
30.17%
200,000
$6,778,000,000 0.29%
Tyra Biosciences Inc
Opened
373,000
$5,964,270,000 0.25%
Century Therapeutics Inc
Closed
1,221,555
$5,106,100,000
Kyverna Therapeutics Inc
Closed
202,333
$5,025,952,000
Emergent Biosolutions Inc
Closed
1,908,000
$4,827,240,000
UiPath, Inc.
Opened
362,000
$4,590,160,000 0.20%
Spyre Therapeutics Inc
Opened
195,000
$4,584,450,000 0.19%
Immatics N.v
Opened
393,100
$4,567,822,000 0.19%
Ionis Pharmaceuticals Inc
28.46%
93,000
$4,432,380,000 0.19%
ARCA biopharma Inc
Opened
1,000,000
$3,830,000,000 0.16%
Editas Medicine Inc
Opened
816,000
$3,810,720,000 0.16%
Intellia Therapeutics Inc
Opened
170,000
$3,804,600,000 0.16%
Collegium Pharmaceutical Inc
67.63%
117,000
$3,767,400,000 0.16%
An2 Therapeutics Inc
Closed
1,150,000
$3,737,500,000
Prime Medicine Inc
65.13%
694,000
$3,567,160,000 0.15%
Ginkgo Bioworks Holdings Inc
Closed
3,000,000
$3,480,000,000
X4 Pharmaceuticals, Inc.
Closed
2,413,000
$3,354,070,000
AC Immune SA
81.54%
825,000
$3,291,750,000 0.14%
Kezar Life Sciences Inc
No change
5,026,000
$3,015,600,000 0.13%
Scynexis Inc
No change
1,448,728
$2,897,456,000 0.12%
Pacific Biosciences Calif In
Closed
675,000
$2,531,250,000
Karyopharm Therapeutics Inc
75.68%
2,018,500
$1,751,251,000 0.07%
Wave Life Sciences Ltd.
Opened
350,000
$1,746,500,000 0.07%
Kodiak Sciences Inc
Closed
300,000
$1,578,000,000
Hyperfine Inc
No change
1,188,178
$1,009,951,000 0.04%
Caremax Inc
No change
21,200
$59,148,000 0.00%
No transactions found
Showing first 500 out of 104 holdings